| Literature DB >> 34959540 |
Jaroslav Bzdil1, Monika Zouharova2, Katerina Nedbalcova2, Vladimir Sladecek1, David Senk1, Ondrej Holy3.
Abstract
The aim of this study was to describe the prevalence of different Staphylococcus species isolated from pathological processes and lesions in domestic animals in the Czech Republic and to detect and describe oxacillin (methicillin)-resistant strains (MRS). During the years 2019-2020, a total of 5218 veterinary clinical samples from the Czech Republic were tested. Testing was performed by culture methods and typing by molecular phenotypic methods MALDI-TOF MS and PCR. Antimicrobial susceptibility testing of the strains was performed by the disk diffusion method. A total of 854 staphylococci strains were identified (16.37% prevalence), out of which 43 strains of 6 species of staphylococci were MRS (n = 43; 0.82% prevalence). Of the MRS strains, the most prevalent species were Staphylococcus pseudintermedius (n = 24; 0.46% prevalence) and Staphylococcus aureus (n = 7; 0.13% prevalence). Susceptibility testing showed resistance to beta-lactam antibiotics and, depending on the species, also to trimethoprim/sulfamethoxazole, gentamicin, tetracycline, erythromycin, clindamycin, and enrofloxacin. For further characterization of MRS, PCR assay for virulence factor genes was performed. Seven of the 14 target genes were observed only in S. aureus, except for the eno gene encoding laminin-binding protein, which was also detected in other staphylococci. It is necessary to emphasize the issue of correct using of antimicrobials in practice and antibiotic policy in university teaching and to create stricter legislation that would prevent the widespread use of antimicrobials in veterinary medicine, especially in livestock to reduce the emergence and spread of antimicrobial resistance.Entities:
Keywords: occurrence; organs; prevalence; susceptibility; veterinary medicine; virulence genes
Year: 2021 PMID: 34959540 PMCID: PMC8706185 DOI: 10.3390/pathogens10121585
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Susceptibility table-reference values for Staphylococcus spp.
| Antimicrobials | Antibiotics Concentration Per Disc (µg) | Diameter (mm) | ||
|---|---|---|---|---|
| R | S | Source | ||
| Cefoxitin ( | 30 | ≤21 | ≥22 | CLSI VET 01 S (2018) |
| Cefoxitin (CNS) | 30 | ≤24 | ≥25 | CLSI VET 01 S (2018) |
| Oxacillin ( | 5 | <20 | ≥20 | CASFM |
| Amoxicillin/clavulanic acid | 20/10 | ≤19 | ≥22 | NCCLS (2002) |
| Trimethoprim/sulfamethoxazole ( | 1.25/23.75 | ≤10 | ≥16 | CLSI VET 01 S (2018) |
| Gentamicin ( | 10 | <18 | ≥18 | EUCAST |
| Gentamicin (CNS) | 10 | <22 | ≥22 | EUCAST |
| Tetracycline ( | 30 | ≤17 | ≥23 | CLSI VET 01 S (2018) |
| Chloramphenicol ( | 30 | ≤12 | ≥18 | CLSI VET 01 S (2018) |
| Erythromycin ( | 15 | ≤13 | ≥23 | CLSI VET 01 S (2018) |
| Florfenicol ( | 30 | ≤18 | ≥22 | CLSI VET 01 (2013) |
| Clindamycin ( | 2 | ≤14 | ≥21 | CLSI VET 01 S (2018) |
| Enrofloxacin ( | 5 | ≤16 | ≥23 | CLSI VET 01 S (2018) |
| Nitrofurantoin ( | 100 | ≤14 | ≥17 | CLSI VET 01 S (2018) |
| Novobiocin | 30 | ≤17 | ≥22 | BD BBL (2020) |
| Rifaximin | 40 | <10 | >19 | BIOPHARM (2020) |
S = susceptible; R = resistant; CNS = coagulase negative staphylococci.
Polymerase chain reaction primers used in this study to detect virulence factor genes in methicillin-resistant staphylococci.
| Gene | Primer | Nucleotide Sequence (5′–3′) | Amplicon Size | Reference |
|---|---|---|---|---|
|
| MECA-1 | GTAGAAATGACTGAACGTCCGATAA | 310 | [ |
| MECA-2 | CCAATTCCACATTGTTTCGGTCTAA | |||
|
| CNA-1 | GTCAAGCAGTTATTAACACCAGAC | 423 | [ |
| CNA-2 | AATCAGTAATTGCACTTTGTCCACTG | |||
|
| ENO-1 | ACGTGCAGCAGCTGACT | 302 | [ |
| ENO-2 | CAACAGCATYCTTCAGTACCTTC | |||
|
| CLFA-1 | ATTGGCGTGGCTTCAGTGCT | 292 | [ |
| CLFA-2 | CGTTTCTTCCGTAGTTGCATTTG | |||
|
| CLFB-1 | ACATCAGTAATAGTAGGGGGCAAC | 205 | [ |
| CLFB-2 | TTCGCACTGTTTGTGTTTGCAC | |||
|
| FIB-1 | CTACAACTACAATTGCCGTCAACAG | 404 | [ |
| FIB-2 | GCTCTTGTAAGACCATTTTCTTCAC | |||
|
| EBP-1 | CATCCAGAACCAATCGAAGAC | 186 | [ |
| EBP-2 | CTTAACAGTTACATCATCATGTTTATCTTTG | |||
|
| BBP-1 | AACTACATCTAGTACTCAACAACAG | 575 | [ |
| BBP-2 | ATGTGCTTGAATAACACCATCATCT | |||
|
| FNBA-1 | CACAACCAGCAAATATAG | 1362 | [ |
| FNBA-2 | CTGTGTGGTAATCAATGTC | |||
|
| FNBB-1 | GTAACAGCTAATGGTCGAATTGATACT | 524 | [ |
| FNBB-2 | CAAGTTCGATAGGAGTACTATGTTC | |||
|
| ICAA-1 | GATTATGTAATGTGCTTGGA | 770 | [ |
| ICAA-2 | ACTACTGCTGCGTTAATAAT | |||
|
| ETA-1 | CTATTTACTGTAGGAGCTAG | 741 | [ |
| ETA-2 | ATTTATTTGATGCTCTCTAT | |||
|
| ETB-1 | ACGGCTATATACATTCAATT | 200 | [ |
| ETB-2 | TCCATCGATAATATACCTAA | |||
|
| TSST-1 | AAGCCCTTTGTTGCTTGCG | 445 | [ |
| TSST-2 | ATCGAACTTTGGCCCATACTTT | |||
Number and prevalence of isolated staphylococci in animals during 1 April 2019–31 May 2020.
| Number of Isolated Strains ( | Prevalence (%) | Number of Isolated Strains ( | Prevalence (%) | ||
|---|---|---|---|---|---|
|
| 205 | 3.93 |
| 3 | 0.06 |
|
| 3 | 0.06 |
| 1 | 0.02 |
| 2 | 0.04 |
| 3 | 0.06 | |
|
| 2 | 0.04 | 1 | 0.02 | |
|
| 1 | 0.02 |
| 336 | 6.44 |
|
| 1 | 0.02 |
| 19 | 0.36 |
|
| 45 | 0.86 | 2 | 0.04 | |
| 1 | 0.02 |
| 18 | 0.34 | |
|
| 3 | 0.06 |
| 11 | 0.21 |
|
| 23 | 0.44 | 2 | 0.04 | |
|
| 7 | 0.13 |
| 1 | 0.02 |
|
| 32 | 0.61 |
| 2 | 0.04 |
|
| 68 | 1.30 |
| 16 | 0.31 |
|
| 6 | 0.11 | |||
|
| 40 | 0.77 | Total | 854 | 16.37 |
* Nomenclature changes byMadhaiyan et al. (2020) [44].
Total number of staphylococci strains (by species) isolated from animals during 1 April 2019–31 May 2020.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Animal (Group) | |||||||||||||||||||||||||||||
| Domestic carnivores | 6 | 0 | 2 | 0 | 1 | 0 | 3 | 0 | 1 | 8 | 0 | 32 | 14 | 0 | 38 | 0 | 0 | 2 | 1 | 333 | 11 | 2 | 2 | 1 | 0 | 0 | 1 | 0 | 458 |
| (dogs and cats) | |||||||||||||||||||||||||||||
| Ruminants | 171 | 3 | 0 | 2 | 0 | 1 | 40 | 1 | 0 | 5 | 1 | 0 | 42 | 1 | 0 | 2 | 0 | 1 | 0 | 0 | 3 | 0 | 10 | 9 | 2 | 1 | 1 | 12 | 308 |
| Pigs | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 18 |
| Solipeds | 12 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 2 | 0 | 6 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29 |
| Birds | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 8 |
| Exotic mammals | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| Exotic birds | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 |
| Rodents | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 24 |
| Total | 205 | 3 | 2 | 2 | 1 | 1 | 45 | 1 | 3 | 23 | 7 | 32 | 68 | 6 | 40 | 3 | 1 | 3 | 1 | 336 | 19 | 2 | 18 | 11 | 2 | 1 | 2 | 16 | 854 |
No staphylococci were isolated from reptiles, insects (bee), and fishes. * Nomenclature changes by Madhaiyan et al. (2020) [44].
Number and prevalence (%) of oxacillin-resistant staphylococci strains isolated from domestic animals during 1 April 2019–31 May 2020.
|
|
|
|
|
|
| Total | Number of Samples | |
|---|---|---|---|---|---|---|---|---|
| Animal (Group) | ||||||||
| Domestic carnivores | 1 (0.04) | 1 (0.04) | 4 (0.16) | 4 (0.16) | 23 (0.93) | 1 (0.04) | 34 (1.38) | 2471 |
| Ruminants | 3 (0.16) | 0 | 0 | 0 | 0 | 0 | 3 (0.16) | 1836 |
| Pigs | 1 (1.41) | 0 | 0 | 0 | 0 | 0 | 1 (1.41) | 71 |
| Solipeds | 1 (1.10) | 0 | 0 | 0 | 0 | 0 | 1 (1.10) | 91 |
| Birds | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 242 |
| Exotic mammals | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 84 |
| Exotic birds | 0 | 1 (0.97) | 0 | 0 | 0 | 0 | 1 (0.97) | 103 |
| Exotic reptiles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 46 |
| Fish | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35 |
| Insects(bees) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Rodents | 1 (0.42) | 0 | 1 (0.42) | 0 | 1 (0.42) | 0 | 3 (1.27) | 236 |
| Total | 7 (0.13) | 2 (0.04) | 5 (0.10) | 4 (0.08) | 24 (0.46) | 1 (0.02) | 43 (0.82) | 5218 |
Number and prevalence (%) of oxacillin-resistant staphylococci strains isolated from organs of domestic animals during 1 April 2019–31 May 2020.
|
|
|
|
|
|
| Total | Number of Samples | |
|---|---|---|---|---|---|---|---|---|
| Organ (Apparatus) | ||||||||
| Ear | 0 | 0 | 0 | 0 | 4 (0.79) | 0 | 4 (0.79) | 507 |
| Eye | 0 | 0 | 0 | 0 | 2 (1.12) | 0 | 2 (1.12) | 179 |
| Skin | 2 (0.46) | 0 | 0 | 4 (0.91) | 14 (3.20) | 1 (0.23) | 21 (4.79) | 438 |
| Respiratory | 1 (0.34) | 1 (0.34) | 4 (1.36) | 0 | 2 (0.68) | 0 | 8 (2.72) | 294 |
| Digestive | 0 | 0 | 0 | 0 | 2 (0.10) | 0 | 2 (0.10) | 1983 |
| Mammary gland | 3 (0.19) | 0 | 0 | 0 | 0 | 0 | 3 (0.19) | 1576 |
| Urogenital | 0 | 1 (0.49) | 1 (0.49) | 0 | 0 | 0 | 2 (0.97) | 206 |
| Musculoskeletal | 1 (3.33) | 0 | 0 | 0 | 0 | 0 | 1 (3.33) | 30 |
| Lymphatic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Circulation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Nervous | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 (0.13) | 2 (0.04) | 5 (0.10) | 4 (0.08) | 24 (0.46) | 1 (0.02) | 43 (0.82) | 5218 |
Susceptibility of oxacillin-resistant strains of staphylococci isolated from domestic animals during 1 April 2019–31 May 2020 to antimicrobials (number of susceptible/examined and percentage of susceptible).
|
|
|
|
|
|
| Total | |
|---|---|---|---|---|---|---|---|
| Antimicrobials | |||||||
| Rifaximin | 7/7 (100%) | 1/2 | 5/5 | 4/4 | 24/24 (100%) | 1/1 (100%) | 42/43 |
| Trimethoprim/ | 6/7 (85.7%) | 1/2 | 0/5 | 2/4 (50.0%) | 11/24 (45.8%) | 1/1 (100%) | 21/43 |
| Gentamicin | 3/7 (42.9%) | 0/2 | 0/5 | 0/4 | 5/24 (20.8%) | 1/1 (100%) | 9/43 |
| Tetracycline | 0/7 | 0/2 | 2/5 | 1/4 (25.0%) | 4/24 (16.7%) | 1/1 (100%) | 8/43 (18.6%) |
| Chloramphenicol | 7/7 (100%) | 2/2 (100%) | 5/5 | 2/4 (50.0%) | 17/24 (70.8%) | 1/1 (100%) | 34/43 |
| Florfenicol | 7/7 (100%) | 2/2 (100%) | 5/5 | 4/4 | 24/24 (100%) | 1/1 (100%) | 43/43 (100%) |
| Erythromycin | 6/7 (85.7%) | 0/2 (0%) | 0/5 | 0/4 | 2/24 | 1/1 (100%) | 9/43 |
| Clindamycin | 5/7 (71.4%) | 1/2 | 2/5 | 0/4 | 2/24 | 1/1 (100%) | 11/43 |
| Enrofloxacin | 3/7 | 0/2 | 0/5 | 0/4 | 0/24 | 0/1 | 3/43 |
| Novobiocin | 7/7 (100%) | 2/2 (100%) | 4/5 | 4/4 | 24/24 (100%) | 1/1 (100%) | 42/43 |
| Nitrofurantoin | 7/7 (100%) | 2/2 (100%) | 5/5 | 4/4 | 24/24 (100%) | 1/1 (100%) | 43/43 (100%) |
Occurrence of virulence factor genes in methicillin-resistant Staphylococcus aureus (n = 7).
| Animal | Matter |
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
| Cat | urine | + | + | - | + | + | - | + |
| Pig | joint | + | + | + | + | + | + | + |
| Cat | skin | + | + | + | + | + | + | + |
| Cow | milk | + | + | + | + | + | + | + |
| Cow | milk | + | + | - | + | + | + | + |
| Horse | skin | + | + | + | + | + | + | + |
| Dog | skin | + | + | + | + | + | + | + |
mecA—gene encoding methicillin resistance, can—collagen-binding protein gene, eno—laminin-binding protein gene, clfA and clfB—genes encoding clumping factors, fib—fibrinogen-binding protein gene, ebp—elastin-binding protein gene, bbp—bone sialoprotein-binding protein gene, fnbA and fnbB—genes encoding fibronectin-binding proteins, icaA—polysaccharide intercellular adhesin gene, etA and etB—exfoliative toxin genes, tsst—toxic shock syndrome toxin gene.